195 related articles for article (PubMed ID: 38774586)
1. Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent.
Jerez HE; Simioni YR; Ghosal K; Morilla MJ; Romero EL
Beilstein J Nanotechnol; 2024; 15():517-534. PubMed ID: 38774586
[TBL] [Abstract][Full Text] [Related]
2. Macrophage apoptosis using alendronate in targeted nanoarchaeosomes.
Jerez HE; Altube MJ; Gándola YB; González L; González MC; Morilla MJ; Romero EL
Eur J Pharm Biopharm; 2021 Mar; 160():42-54. PubMed ID: 33440242
[TBL] [Abstract][Full Text] [Related]
3. Make It Simple: (SR-A1+TLR7) Macrophage Targeted NANOarchaeosomes.
Parra FL; Caimi AT; Altube MJ; Cargnelutti DE; Vermeulen ME; de Farias MA; Portugal RV; Morilla MJ; Romero EL
Front Bioeng Biotechnol; 2018; 6():163. PubMed ID: 30460231
[TBL] [Abstract][Full Text] [Related]
4. Fast Biofilm Penetration and Anti-PAO1 Activity of Nebulized Azithromycin in Nanoarchaeosomes.
Altube MJ; Martínez MMB; Malheiros B; Maffía PC; Barbosa LRS; Morilla MJ; Romero EL
Mol Pharm; 2020 Jan; 17(1):70-83. PubMed ID: 31617725
[TBL] [Abstract][Full Text] [Related]
5. The Anti-Inflammatory Effect of Nanoarchaeosomes on Human Endothelial Cells.
Charó N; Jerez H; Tatti S; Romero EL; Schattner M
Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456570
[TBL] [Abstract][Full Text] [Related]
6. Vascular response to stress: Protective action of the bisphosphonate alendronate.
Cutini PH; Campelo AE; Massheimer VL
Vasc Med; 2022 Oct; 27(5):425-432. PubMed ID: 35879908
[TBL] [Abstract][Full Text] [Related]
7. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
[TBL] [Abstract][Full Text] [Related]
8. Study on in vitro release and cell response to alendronate sodium-loaded ultrahigh molecular weight polyethylene loaded with alendronate sodium wear particles to treat the particles-induced osteolysis.
Qu S; Bai Y; Liu X; Fu R; Duan K; Weng J
J Biomed Mater Res A; 2013 Feb; 101(2):394-403. PubMed ID: 22847941
[TBL] [Abstract][Full Text] [Related]
9. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic Therapy with Nebulized Nanocurcumin on A549 Cells, Model Vessels, Macrophages and Beyond.
Altube MJ; Caputo EN; Rivero MN; Gutiérrez ML; Romero EL
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559132
[TBL] [Abstract][Full Text] [Related]
11. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
Feng S; Wu ZX; Zhao Z; Liu J; Sun K; Guo C; Wang H; Wu Z
ACS Appl Mater Interfaces; 2019 Feb; 11(7):7357-7368. PubMed ID: 30682240
[TBL] [Abstract][Full Text] [Related]
12. Superoxide dismutase in nanoarchaeosomes for targeted delivery to inflammatory macrophages.
Schilrreff P; Simioni YR; Jerez HE; Caimi AT; de Farias MA; Villares Portugal R; Romero EL; Morilla MJ
Colloids Surf B Biointerfaces; 2019 Jul; 179():479-487. PubMed ID: 31005743
[TBL] [Abstract][Full Text] [Related]
13. Alendronate conjugate for targeted delivery to bone-forming prostate cancer.
Damasco JA; Yu G; Kumar A; Perez J; Lirag RCM; Whitley EM; Lin SH; Melancon MP
Talanta; 2023 May; 256():124308. PubMed ID: 36774896
[TBL] [Abstract][Full Text] [Related]
14. Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia.
Wu H; Gao Y; Ma J; Hu M; Xia J; Bao S; Liu Y; Feng K
Regen Biomater; 2022; 9():rbac058. PubMed ID: 36110161
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod-loaded nanoarchaeosomes as a promising immunotherapy against Trypanosoma cruzi infection.
Parra FL; Frank FM; Alliani BF; Romero EL; Petray PB
Colloids Surf B Biointerfaces; 2020 May; 189():110850. PubMed ID: 32058257
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vitro antitumor activity evaluation of hyaluronic acid-alendronate-methotrexate nanoparticles.
Gao C; Wang M; Zhu P; Yan C
Int J Biol Macromol; 2021 Jan; 166():71-79. PubMed ID: 33091477
[TBL] [Abstract][Full Text] [Related]
17. Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa.
Higa LH; Jerez HE; de Farias MA; Portugal RV; Romero EL; Morilla MJ
Nanomedicine (Lond); 2017 May; 12(10):1165-1175. PubMed ID: 28447893
[TBL] [Abstract][Full Text] [Related]
18. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy.
Xi Y; Jiang T; Yu Y; Yu J; Xue M; Xu N; Wen J; Wang W; He H; Shen Y; Chen D; Ye X; Webster TJ
Int J Nanomedicine; 2019; 14():6425-6437. PubMed ID: 31496695
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of recombinant human parathyroid hormone (1-34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis.
Deng J; Feng Z; Li Y; Pan T; Li Q; Zhao C
Medicine (Baltimore); 2018 Nov; 97(47):e13341. PubMed ID: 30461654
[TBL] [Abstract][Full Text] [Related]
20. Alendronate inhibits osteocyte apoptosis and inflammation via IL-6, inhibiting bone resorption in periapical lesions of ovariectomized rats.
Silva RAB; Sousa-Pereira AP; Lucisano MP; Romualdo PC; Paula-Silva FWG; Consolaro A; Silva LAB; Nelson-Filho P
Int Endod J; 2020 Jan; 53(1):84-96. PubMed ID: 31429089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
